Article Details

Scopus BioPharma Expands Immunotherapy Pipeline with Acquisition of Olimmune

Retrieved on: 2021-06-30 13:30:00

Tags for this article:

Click the tags to see associated articles and topics

Scopus BioPharma Expands Immunotherapy Pipeline with Acquisition of Olimmune. View article details on hiswai:

Excerpt

NEW YORK, June 30, 2021 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (Nasdaq: “SCPS”), a clinical-stage biopharmaceutical company developing ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo